Immunotherapy and immunoprophylaxis in the newborn infant: the need for definitive clinical trials
- PMID: 2194265
- DOI: 10.1093/clinids/12.supplement_4.s392
Immunotherapy and immunoprophylaxis in the newborn infant: the need for definitive clinical trials
Similar articles
-
[Current problems in the immunoprophylaxis and immunotherapy of burn infection].Gematol Transfuziol. 1984 Jul;29(7):9-12. Gematol Transfuziol. 1984. PMID: 6468913 Russian. No abstract available.
-
[Neonatal sepsis: bases and possibilities for immunotherapy and immunoprophylaxis. 3: Immunoprophylaxis].Padiatr Grenzgeb. 1990;29(5):373-6. Padiatr Grenzgeb. 1990. PMID: 2234978 Review. German.
-
[Neonatal sepsis: bases and possibilities for immunotherapy and immunoprophylaxis. 2: Immunotherapy].Padiatr Grenzgeb. 1990;29(5):363-71. Padiatr Grenzgeb. 1990. PMID: 2234977 Review. German.
-
Neonatal sepsis: the potential for immunotherapy.Clin Perinatol. 1988 Dec;15(4):755-71. Clin Perinatol. 1988. PMID: 3061698 Review.
-
The role of intravenous immunoglobulin in the treatment and prevention of neonatal bacterial infection.Semin Perinatol. 1991 Jun;15(3 Suppl 2):41-6. Semin Perinatol. 1991. PMID: 1887261 Review. No abstract available.
Cited by
-
Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants.Cochrane Database Syst Rev. 2020 Jan 29;1(1):CD000361. doi: 10.1002/14651858.CD000361.pub4. Cochrane Database Syst Rev. 2020. PMID: 31995650 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical